- Docket Number:
- None found
- Issued by:
Guidance Issuing OfficeCenter for Drug Evaluation and Research
From time to time persons question whether or not candy pills should be subjected to regulatory action based on misbranding under Section 403(a) in that they are represented as pills which they are not.
We are not prepared to take regulatory action against these products solely on the basis that they are labeled as "candy pills".
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: None found.